Benitec Biopharma (BNTC) Other Accumulated Expenses (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Other Accumulated Expenses for 7 consecutive years, with $157000.0 as the latest value for Q1 2025.
- Quarterly Other Accumulated Expenses rose 98.73% to $157000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $157000.0 through Mar 2025, up 98.73% year-over-year, with the annual reading at $138000.0 for FY2024, 100.0% up from the prior year.
- Other Accumulated Expenses hit $157000.0 in Q1 2025 for Benitec Biopharma, up from $92000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $223000.0 in Q4 2021 to a low of $36000.0 in Q1 2023.
- Historically, Other Accumulated Expenses has averaged $96764.7 across 5 years, with a median of $79000.0 in 2024.
- Biggest five-year swings in Other Accumulated Expenses: surged 145.05% in 2021 and later crashed 81.61% in 2022.
- Year by year, Other Accumulated Expenses stood at $223000.0 in 2021, then tumbled by 81.61% to $41000.0 in 2022, then skyrocketed by 80.49% to $74000.0 in 2023, then increased by 24.32% to $92000.0 in 2024, then soared by 70.65% to $157000.0 in 2025.
- Business Quant data shows Other Accumulated Expenses for BNTC at $157000.0 in Q1 2025, $92000.0 in Q4 2024, and $59000.0 in Q3 2024.